Long-term renal effects of unilateral ureteral obstruction and the role of endothelin

Kidney International

Volumn 58, Issue 1, 2000, Pages 242-250

  Hammad, Fayez T ^a   Wheatley, Antony M ^a   Davis, Gerard ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Angiotensin II; Bosentan; Captopril; Hemodynamics; Vasoconstriction

Indexed keywords

ANGIOTENSIN; BOSENTAN; CAPTOPRIL; ENDOTHELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URETER OBSTRUCTION; URINE FLOW RATE; URINE VOLUME; VASOCONSTRICTION;

EID: 0033935807     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00159.x     Document Type: Article

References (51)

1. 1. KLAHR S, HARRIS K, PURKERSON ML: Effects of obstruction on renal functions. Pediatr Nephrol 2:34-42, 1988
2. 2. WRIGHT F: Effects of urinary tract obstruction on glomerular filtration rate and renal blood flow. Semin Nephrol 2:5-16, 1982
3. 3. KLAHR S: Pathophysiology of obstructive nephropathy. Kidney Int 23:414-426, 1983
4. 4. BANDER SJ, BUERKERT JE, MARTIN D, KLAHR S: Long-term effects of 24-hr unilateral ureteral obstruction on renal function in the rat. Kidney Int 28:614-620, 1985
5. 5. INOUE A, YANAGISAWA M, KIMURA S, KASUYA Y, MIYAUCHI T, GOTO K, MASAKI T: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867, 1989
6. 6. SAKURAI T, YANAGISAWA M, MASAKI T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-108, 1992
7. 7. BROOKS DP: Role of endothelin in renal function and dysfunction. Clin Exp Pharmacol Physiol 23:345-348, 1996
8. 8. JOSEPHSON S, HEMSEN A: Renal tissue endothelin in long-term complete ureteric obstruction in the young rat. Urol Int 53:57-61, 1994
9. 9. REYES AA, KLAHR S: Renal function after release of ureteral obstruction: Role of endothelin and the renal artery endothelium. Kidney Int 42:632-638, 1992
10. B receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int 50:962-972, 1996
11. 11. BENIGNI A, ZOLA C, CORNA D, ORISIO S, FACCHINETTI D, BENATI L, REMUZZI G: Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am J Kidney Dis 27:416-423, 1996
12. 12. KARAM H, BRUNEVAL P, CLOZEL JP, LOFFLER BM, BARIETY J, CLOZEL M: Role of endothelin in acute renal failure due to rhabdomyolysis in rats. J Pharmacol Exp Ther 274:481-486, 1995
13. 13. JOHNS EJ: Role of angiotensin II and the sympathetic nervous system in the control of renal function. J Hypertens 7:695-701, 1989
14. 14. HALL JE, GUYTON AC, MIZELLE HL: Role of the renin-angiotensin system in control of sodium excretion and arterial pressure. Acta Physiol Scand (Suppl 591):48-62, 1990
15. 15. KALOYANIDES GJ, BASTRON RD, DIBONA GF: Effect of ureteral clamping and increased renal arterial pressure on renin release. Am J Physiol 225:95-99, 1973
16. 16. PURKERSON ML, KLAHR S: Prior inhibition of vasoconstrictors normalizes GFR in postobstructed kidneys. Kidney Int 35:1305-1314, 1989
17. 17. VAUGHAN E JR, SHENASKY JD, GILLENWATER JY: Mechanism of acute hemodynamic response to ureteral occlusion. Invest Urol 9:109-118, 1971
18. 18. NISHIKAWA K, MORRISON A, NEEDLEMAN P: Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J Clin Invest 59:1143-1150, 1977
19. 19. NAGLE RB, EVANS LW, REYNOLDS DG: Contractility of renal cortex following complete ureteral obstruction. Proc Soc Exp Biol Med 148:611-614, 1975
20. 20. KLAHR S, HARRIS K: Obstructive uropathy, in The Kidney: Physiology and Pathophysiology (3) (2nd ed), edited by SELDIN DW, GIEBISCH G, New York, Raven Press, 1992, pp 3327-3370
21. 21. ZUCCARELLO M, SOATTIN GB, LEWIS AI, BREU V, HALLAK H, RAPOPORT RM: Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 84:503-507, 1996
22. 22. CLOZEL M, BREU V, GRAY GA, KALINA B, LOFFLER BM, BURRI K, CASSAL JM, HIRTH G, MULLER M, NEIDHART W, RAMUZ H: Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 270:228-235, 1994
23. 23. NEYLON M, MARSHALL JM, JOHNS EJ: The effects of systemic hypoxia on renal function in the anaesthetized rat. J Physiol 487:497-511, 1995
24. 24. SZENASI G, KOTTRA G, BENCSATH P, TAKACS L: Renal nerves in exaggerated water and sodium excretion by hypertrophied kidney of anesthetized rats. Am J Physiol 254:F32-F37, 1988
25. 25. HANDA RK, JOHNS EJ: Interaction of the renin-angiotensin system and the renal nerves in the regulation of rat kidney function. J Physiol 369:311-321, 1985
26. 26. BOJESEN E: A method for determination of inulin in plasma and urine. Acta Med Scand 142:275-282, 1951
27. 27. BRATTON CA, MARSHALL EK: A new coupling component for Sulfanil-amide determination. J Biol Chem 128:537-550, 1939
28. 28. MCDOUGAL WS, WRIGHT FS: Defect in proximal and distal sodium transport in post-obstructive diuresis. Kidney Int 2:304-317, 1972
29. 29. PROVOOST AP, MOLENAAR JC: Renal function during and after a temporary complete unilateral ureter obstruction in rats. Invest Urol 18:242-246, 1981
30. 30. MOODY TE, VAUGHN E JR, GILLENWATER JY: Relationship between renal blood flow and ureteral pressure during 18 hours of total unilateral uretheral occlusion: Implications for changing sites of increased renal resistance. Invest Urol 13:246-251, 1975
31. 31. HARRIS RH, GILL JM: Changes in glomerular filtration rate during complete ureteral obstruction in rats. Kidney Int 19:603-608, 1981
32. 32. HALL JE, COLEMAN TG, GUYTON AC, KASTNER PR, GRANGER JP: Control of glomerular filtration rate by circulating angiotensin II. Am J Physiol 241:R190-R197, 1981
33. 33. MATTSON DL, ROMAN RJ: Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Am J Physiol 260:F670-F679, 1991
34. 34. REID IA: Interaction between Ang II, sympathetic nervous system and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262:E763-E778, 1992
35. 35. RUBIN B, LAFFAN RJ, KOTLER DG, O'KEEFE EH, DEMAIO DA, GOLDBERG ME: SQ 14,225 (D-3-mercapto-2-methylpropanoyl-1-proline), a novel orally active inhibitor of angiotensin I-converting enzyme. J Pharmacol Exp Ther 204:271-280, 1978
36. 36. BARRACLOUGH MA, JONES NF, MARSDEN CD: Effect of angiotensin on renal function in the rat. Am J Physiol 212:1153-1157, 1967
37. 37. AMIRI F, GARCIA R: Differential regulation of renal glomerular and preglomerular vascular angiotensin II receptors. Am J Physiol 270:E810-E815, 1996
38. 38. PIMENTEL JL JR, WANG S, MARTINEZ-MALDONADO M: Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction. Kidney Int 45:1614-1621, 1994
39. 39. HALL JE, COLEMAN TG, GUYTON AC, BALFE JW, SALGADO HC: Intrarenal role of angiotensin II and [des-Asp1]angiotensin II. Am J Physiol 236:F252-F259, 1979
40. 40. HALL JE, GUYTON AC, JACKSON TE, COLEMAN TG, LOHMEIER TE, TRIPPODO NC: Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233:F366-F372, 1977
41. 41. DING Y, CHANG S, SHIEH S, HUANG W: Antihypertensive and renal effects of cilazapril and their reversal by angiotensin in renovascular hypertensive rats. Clin Sci 74:365-372, 1988
42. 42. HARRIS PJ, HIRANYACHATTADA S, ANTOINE AM, WALKER L, REILLY AM, EITLE E: Regulation of renal tubular sodium transport by angiotensin II and atrial natriuretic factor. Clin Exp Pharmacol Physiol 3(Suppl):S112-S118, 1996
43. 43. EDWARDS RM, TRIZNA W, OHLSTEIN EH: Renal microvascular effects of endothelin. Am J Physiol 259:F217-F221, 1990
44. 44. HORI S, KOMATSU Y, SHIGEMOTO R, MIZUNO N, NAKANISHI S: Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130:1885-1895, 1992
45. 45. BADR KF, MURRAY JJ, BREYER MD, TAKAHASHI K, INAGAMI T, HARRIS RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney: Elucidation of signal transduction pathways. J Clin Invest 83:336-342, 1989
46. 46. KON V, YOSHIOKA T, FOGO A, ICHIKAWA I: Glomerular actions of endothelin in vivo. J Clin Invest 83:1762-1767, 1989
47. 47. SIMONSON MS, DUNN MJ: The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J Lab Clin Med 119:622-639, 1992
48. 48. BURNS KD, HOMMA T, HARRIS RC: The intrarenal renin-angiotensin system. Semin Nephrol 13:13-30, 1993
49. 49. LARGO R, GOMEZ-GARRE D, LIU XH, ALONSO J, BLANCO J, PLAZA JJ, EGIDO J: Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril. Hypertension 29:1178-1185, 1997
50. 50. CLAVELL AL, BURNETT JC JR: Physiologic and pathophysiologic roles of endothelin in the kidney. Curr Opin Nephrol Hypertens 3:66-72, 1994
51. 51. RECKELHOFF JF, SAMSELL L, DEY R, RACUSEN L, BAYLIS C: The effect of aging on glomerular hemodynamics in the rat. Am J Kidney Dis 20:70-75, 1992